Nath Bio-Genes (India) Limited

Nath Bio-Genes (NSE:NATHBIOGEN): Has It Filed the Q2 FY27 Depository Compliance Certificate?
Kalkine India · 21 Oct 2026
Nath Bio-Genes (NATHBIOGEN.NS) Slips 1.43% to ₹135.71 as Seed Counter Tests Near-Term Support - Earnings Sentiment
https://www.siam.in/ · 19 Oct 2026
Nath Bio-Genes (India) Limited Q2 2026 Earnings: Strong 21.98% Revenue Growth Offset by Softer Stock Reaction
https://www.siam.in/ · 02 Oct 2026
Is Nath Bio-Genes India the Best Stock in Its Sector? A Look at the Numbers
Univest · 01 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.